JP2003530349A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003530349A5 JP2003530349A5 JP2001574107A JP2001574107A JP2003530349A5 JP 2003530349 A5 JP2003530349 A5 JP 2003530349A5 JP 2001574107 A JP2001574107 A JP 2001574107A JP 2001574107 A JP2001574107 A JP 2001574107A JP 2003530349 A5 JP2003530349 A5 JP 2003530349A5
- Authority
- JP
- Japan
- Prior art keywords
- plaque
- skin
- skin disease
- ointment
- thyroid hormone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20000818A FI107018B (fi) | 2000-04-06 | 2000-04-06 | Dermatologinen käyttö ja valmiste |
| FI20000818 | 2000-04-06 | ||
| PCT/FI2001/000100 WO2001076589A1 (en) | 2000-04-06 | 2001-02-05 | Dermatological use and a dermatological preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003530349A JP2003530349A (ja) | 2003-10-14 |
| JP2003530349A5 true JP2003530349A5 (OSRAM) | 2007-06-07 |
Family
ID=8558139
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001574107A Pending JP2003530349A (ja) | 2000-04-06 | 2001-02-05 | 皮膚病用の使用方法及び皮膚病用薬剤 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20030144359A1 (OSRAM) |
| EP (1) | EP1274416A1 (OSRAM) |
| JP (1) | JP2003530349A (OSRAM) |
| AU (1) | AU2001235506A1 (OSRAM) |
| CA (1) | CA2405425A1 (OSRAM) |
| CH (1) | CH695983A5 (OSRAM) |
| DE (1) | DE10196025T1 (OSRAM) |
| DK (1) | DK200201483A (OSRAM) |
| ES (1) | ES2193003B1 (OSRAM) |
| FI (1) | FI107018B (OSRAM) |
| GB (1) | GB2377380B (OSRAM) |
| NO (1) | NO20024810L (OSRAM) |
| SE (1) | SE0202886L (OSRAM) |
| WO (1) | WO2001076589A1 (OSRAM) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11508241A (ja) * | 1995-06-07 | 1999-07-21 | カロ バイオ エービー | 甲状腺ホルモンまたは甲状腺ホルモン様化合物に関する新規な使用 |
| US8668926B1 (en) | 2003-09-15 | 2014-03-11 | Shaker A. Mousa | Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof |
| US9198887B2 (en) | 2003-09-15 | 2015-12-01 | Nanopharmaceuticals Llc | Thyroid hormone analogs and methods of use |
| JP2007505837A (ja) * | 2003-09-15 | 2007-03-15 | オードウェイ リサーチ インスティテュート | 甲状腺ホルモンアナログおよび新脈管形成における使用の方法 |
| US9498536B2 (en) | 2005-09-15 | 2016-11-22 | Nanopharmaceuticals Llc | Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders |
| US10130686B2 (en) | 2005-09-15 | 2018-11-20 | Nanopharmaceuticals Llc | Method and composition of thyroid hormone analogues and nanoformulations thereof for treating inflammatory disorders |
| US9220788B2 (en) | 2009-06-17 | 2015-12-29 | Nanopharmaceuticals Llc | Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof |
| WO2007035612A2 (en) | 2005-09-16 | 2007-03-29 | Ordway Research Institute, Inc. | Polyphenol conjugates as rgd-binding compounds and methods of use |
| JP2010513526A (ja) | 2006-12-22 | 2010-04-30 | シーエルエフ メディカル テクノロジー アクセラレーション プログラム インコーポレイテッド | 甲状腺ホルモン類縁体、拮抗剤および製剤のためのナノ粒子及び重合体製剤ならびにその使用 |
| WO2010075332A1 (en) * | 2008-12-23 | 2010-07-01 | Charitable Leadership Foundation | Small molecule ligands of the integrin rgd recognition site and methods of use |
| US9180107B2 (en) | 2009-03-31 | 2015-11-10 | Nanopharmaceuticals Llc | Combination treatment of cancer with cetuximab and tetrac |
| US8802240B2 (en) | 2011-01-06 | 2014-08-12 | Nanopharmaceuticals Llc | Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells |
| US10201616B2 (en) | 2016-06-07 | 2019-02-12 | Nanopharmaceuticals, Llc | Non-cleavable polymer conjugated with αVβ3 integrin thyroid antagonists |
| US11351137B2 (en) | 2018-04-11 | 2022-06-07 | Nanopharmaceuticals Llc | Composition and method for dual targeting in treatment of neuroendocrine tumors |
| US10328043B1 (en) | 2018-04-11 | 2019-06-25 | Nanopharmaceuticals, Llc. | Composition and method for dual targeting in treatment of neuroendocrine tumors |
| US10961204B1 (en) | 2020-04-29 | 2021-03-30 | Nanopharmaceuticals Llc | Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors |
| US11723888B2 (en) | 2021-12-09 | 2023-08-15 | Nanopharmaceuticals Llc | Polymer conjugated thyrointegrin antagonists |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB859546A (en) * | 1956-05-29 | 1961-01-25 | Arthur Alfred Hellbaum | Composition for treatment of the skin |
| US3198702A (en) * | 1960-03-17 | 1965-08-03 | Arthur A Hellbaum | Method for treating skin burns |
| CA2184002A1 (en) * | 1994-02-23 | 1995-08-31 | Jeffrey M. Blaney | Method and compositions for increasing the serum half-life of pharmacologically active agents |
| US6380255B1 (en) * | 1995-06-07 | 2002-04-30 | Karo Bio Ab | Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds |
| JPH11508241A (ja) * | 1995-06-07 | 1999-07-21 | カロ バイオ エービー | 甲状腺ホルモンまたは甲状腺ホルモン様化合物に関する新規な使用 |
| HUT75956A (en) * | 1995-11-29 | 1997-05-28 | Cyclolab | Pharmaceutical composition containing thyroxine |
| US5951989A (en) * | 1997-04-07 | 1999-09-14 | Heymann; Warren R. | Method for the treatment of dry skin |
| GB9828442D0 (en) * | 1998-12-24 | 1999-02-17 | Karobio Ab | Novel thyroid receptor ligands and method II |
| EP1173163B1 (en) * | 1999-04-26 | 2006-06-21 | Elliot Danforth, Jr. | Pharmaceutical compositions of tetrac and methods of use thereof |
| US6716877B2 (en) * | 2001-01-31 | 2004-04-06 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Method to treat chronic heart failure and/or elevated cholesterol levels |
-
2000
- 2000-04-06 FI FI20000818A patent/FI107018B/fi active
-
2001
- 2001-02-05 DK DK200201483A patent/DK200201483A/da not_active Application Discontinuation
- 2001-02-05 CH CH01666/02A patent/CH695983A5/de not_active IP Right Cessation
- 2001-02-05 US US10/239,882 patent/US20030144359A1/en not_active Abandoned
- 2001-02-05 CA CA002405425A patent/CA2405425A1/en not_active Abandoned
- 2001-02-05 DE DE10196025T patent/DE10196025T1/de not_active Withdrawn
- 2001-02-05 GB GB0222880A patent/GB2377380B/en not_active Expired - Fee Related
- 2001-02-05 ES ES200250061A patent/ES2193003B1/es not_active Expired - Fee Related
- 2001-02-05 AU AU2001235506A patent/AU2001235506A1/en not_active Abandoned
- 2001-02-05 JP JP2001574107A patent/JP2003530349A/ja active Pending
- 2001-02-05 EP EP01907581A patent/EP1274416A1/en not_active Ceased
- 2001-02-05 WO PCT/FI2001/000100 patent/WO2001076589A1/en not_active Ceased
-
2002
- 2002-10-01 SE SE0202886A patent/SE0202886L/ not_active Application Discontinuation
- 2002-10-04 NO NO20024810A patent/NO20024810L/no not_active Application Discontinuation
-
2005
- 2005-08-08 US US11/198,133 patent/US20050272817A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100479669B1 (ko) | Igf-1의레벨증가에유용한l-아세틸카르니틴,l-이소발레릴카르니틴,l-프로피오닐카르니틴의용도 | |
| Katayama et al. | Exacerbation of psoriasis induced by indomethacin | |
| KR101954869B1 (ko) | 탈모증 치료제 | |
| KR101533695B1 (ko) | 피부 외용제 조성물 | |
| JPH0651626B2 (ja) | 組織退行性炎症性疾患の治療用組成物 | |
| US20030077332A1 (en) | Topical zinc compositions and methods of use | |
| JP2003530349A (ja) | 皮膚病用の使用方法及び皮膚病用薬剤 | |
| JP4044611B2 (ja) | プロスタグランジンの新たな使用 | |
| AU754420B2 (en) | Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases | |
| WO2022178144A1 (en) | Remittive effects of tapinarof in the treatment of plaque psoriasis, atopic dermatitis, or radiation dermatitis | |
| JP2002542284A (ja) | テトラックの薬学組成物およびその使用方法 | |
| JPH0399019A (ja) | 毛細血管脆弱の処置の局所的使用のための製薬学的組成物 | |
| JPH09509139A (ja) | 酪酸エステル細胞分化薬 | |
| JPH07309820A (ja) | Ｌ−カルニチンの芳香族酸とのｏ−エステル類を含む皮膚病処置のための医薬組成物 | |
| KR20070040371A (ko) | 혈장 지질을 낮추기 위한 알파 케토글루타레이트 및 관련화합물의 용도 | |
| JP3830963B2 (ja) | 乾癬治療 | |
| JP5033381B2 (ja) | 外用医薬組成物 | |
| JP5460766B2 (ja) | 外用医薬組成物 | |
| Vuopala et al. | Dimethyl Sulfoxide (DMSO) Ointment in the Treatment of Rheumatoid Arthritis: A Double Blind Study | |
| US9452117B2 (en) | Nitrate esters and their use for the treatment of muscle and muscle related diseases | |
| Katsambas et al. | Localized myxedema in Grave's disease confined to the toes. | |
| Simpson et al. | Trends in topical psoriasis therapy. | |
| WO2025077886A1 (zh) | 治疗和/或预防日光性角化病的化合物及方法 | |
| Morhenn | Effect of Nitroglycerin Ointment on Psoriatic Plaques | |
| JPH10203995A (ja) | 抗骨粗鬆症剤 |